🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The optimal antithrombotic therapy for patients with atrial fibrillation (A...
Status
Unknown
Location
Onze Lieve Vrouw Ziekenhuis
Start Date
2014-06
Trial ID
NCT02635230
Treatments Being Tested
Dual antiplatelet therapy with acetylsalicylic acid (ASA, aspirin) and clop...
Status
Completed
Location
Cardiovascular Center, Ruhr University Bochum, St. Josef - Hospital, Gudrunstrasse 56
Start Date
2008-10
Trial ID
NCT01212302
Treatments Being Tested
Rationale: Heart attacks are a major cause of death and result from coronar...
Status
Recruiting
Location
Aalborg University Hospital
Start Date
2022-06-17
Trial ID
NCT05262803
Treatments Being Tested
The purpose of this study is to see if one month of dual antiplatelet thera...
Status
Terminated
Location
HonorHealth Research Institute
Start Date
2018-11-19
Trial ID
NCT03606642
Treatments Being Tested
The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-20
Trial ID
NCT02293395
Treatments Being Tested
The DAPT Study is a double blind randomized controlled trial intended to de...
Status
Completed
Location
Thomas Hospital
Start Date
2009-10
Trial ID
NCT00977938
Treatments Being Tested
The current study aims to investigate whether combining the standard medica...
Status
Recruiting
Location
Baylor Scott and White Health System
Start Date
2025-12-05
Trial ID
NCT07032389
Treatments Being Tested
The Purpose of this open-label randomized controlled multicenter trial is t...
Status
Terminated
Location
National Hospital Organization Osaka National Hospital
Start Date
2017-04-06
Trial ID
NCT03062319
Treatments Being Tested
The purpose of this study is to assess the the 1-year rates of ischemic and...
Status
Completed
Location
Mount Sinai Medical Center
Start Date
2012-03
Trial ID
NCT01582217
Primary percutaneous coronary intervention (PCI) is the preferred revascula...
Status
Recruiting
Location
Geneva University Hospitals
Start Date
2025-11-01
Trial ID
NCT05785897